Internal Medicine, Hematology & Oncology · Livingston, NJ
NPI
1124020052
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
94 Old Short Hills Rd
Livingston, NJ, 07039
Phone (973) 322-5200
Groups this clinician bills Medicare through
Medicare paid, 2024
$374K
16,265 services
Medicare patients, 2024
460
Average age 77
Drug cost, 2024
$3.0M
857 prescriptions
Company payments, 2025
$346
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David H Gallinson was code 36415 (venipuncture blood collection), 566 times for 252 patients. In total David H Gallinson billed 16,265 services in 133 codes, and Medicare paid $374K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 566 | 252 | $8.60 | $4,870 |
| 85025 Blood Count | Office | 565 | 251 | $7.39 | $4,178 |
| 99215 Office E&M - Established | Office | 517 | 200 | $147.42 | $76K |
| 99214 Office E&M - Established | Office | 515 | 265 | $104.41 | $54K |
| 80053 Clinical Chemistry | Office | 410 | 224 | $10.03 | $4,112 |
| 82728 Clinical Chemistry | Office | 130 | 84 | $13.26 | $1,723 |
| 82784 Immunoassay | Office | 124 | 36 | $9.11 | $1,130 |
| 83550 Clinical Chemistry | Office | 112 | 74 | $8.49 | $951 |
| 83540 Clinical Chemistry | Office | 112 | 74 | $6.28 | $704 |
| 99232 Hospital E&M - Subsequent | Facility | 78 | 47 | $65.40 | $5,102 |
| 99205 Office E&M - New | Office | 58 | 58 | $187.72 | $11K |
| 83521 Immunoassay | Office | 57 | 27 | $16.92 | $965 |
| 83735 Clinical Chemistry | Office | 51 | 33 | $5.93 | $302 |
| 84550 Clinical Chemistry | Office | 50 | 27 | $4.16 | $208 |
| 99233 Hospital E&M - Subsequent | Facility | 42 | 26 | $99.74 | $4,189 |
By year: 2022 $202K for 11,607 services; 2023 $352K for 19,787 services; 2024 $374K for 16,265 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 566 | 252 | $8.60 | $4,870 |
| 85025 Blood Count | 565 | 251 | $7.39 | $4,178 |
| 80053 Clinical Chemistry | 410 | 224 | $10.03 | $4,112 |
| 82728 Clinical Chemistry | 130 | 84 | $13.26 | $1,723 |
| 82784 Immunoassay | 124 | 36 | $9.11 | $1,130 |
| 83550 Clinical Chemistry | 112 | 74 | $8.49 | $951 |
| 83540 Clinical Chemistry | 112 | 74 | $6.28 | $704 |
| 83521 Immunoassay | 57 | 27 | $16.92 | $965 |
| 83735 Clinical Chemistry | 51 | 33 | $5.93 | $302 |
| 84550 Clinical Chemistry | 50 | 27 | $4.16 | $208 |
Medicare prescription drug claims, 2024
In 2024, the drug David H Gallinson prescribed most often to Medicare patients was Eliquis (Apixaban), with 104 prescriptions and refills. In total David H Gallinson wrote 857 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 104 | 146 | 20 | $81K |
| Xarelto Rivaroxaban | 84 | 156 | 21 | $85K |
| Hydroxyurea Generic | 55 | 142 | 18 | $1,957 |
| Calquence Acalabrutinib Maleate | 44 | 44 | Under 11 | $673K |
| Anastrozole Generic | 43 | 113 | 12 | $1,084 |
| Dexamethasone Generic | 39 | 50 | 11 | $1,047 |
| Gabapentin Generic | 19 | 31 | Under 11 | $614 |
| Tramadol Hcl Generic | 18 | 18 | Under 11 | $200 |
| Acyclovir Generic | 18 | 34 | Under 11 | $235 |
| Alprazolam Generic | 18 | 19 | Under 11 | $96.53 |
| Imbruvica Ibrutinib | 17 | 17 | Under 11 | $208K |
| Prednisone Generic | 17 | 25 | Under 11 | $149 |
| Imatinib Mesylate Generic | 16 | 16 | Under 11 | $13K |
| Promacta Eltrombopag Olamine | 15 | 15 | Under 11 | $123K |
| Brukinsa Zanubrutinib | 13 | 13 | Under 11 | $191K |
Brand drugs: - claims; generic drugs: 481 claims; opioid claims: 44.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David H Gallinson $346 ($346 in general payments such as food, travel and fees) from 7 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $122.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.